Mixed Analyst Opinions on Healthcare Stocks ATEC, AMGN, VRTX

Analysts have been weighing in on several healthcare stocks, including Alphatec Holdings (ATEC), Amgen (AMGN), and Vertex Pharmaceuticals (VRTX). According to TipRanks, a research platform that aggregates analyst opinions and data, these three companies have garnered significant attention from industry experts.

Tipcakings indicates that Needham's David Saxon has reiterated his Buy rating on Alphatec Holdings with a price target of $14.00. The company's shares closed last Tuesday at $10.35, and the analyst consensus is a Strong Buy with an average price target of $16.42, implying a 64.9% upside from current levels.

On the other hand, Wells Fargo's Mohit Bansal has maintained his Hold rating on Amgen with a price target of $400.00. The company's shares closed last Tuesday at $390.02, and the analyst consensus is a Moderate Buy with an average price target of $369.00, which is a -3.1% downside from current levels.

Goldman Sachs' Salveen Richter has assigned a Buy rating to Vertex Pharmaceuticals with a price target of $653.00. The company's shares closed last Tuesday at $478.71, and the analyst consensus is a Strong Buy with an average price target of $559.00, representing an 18.6% upside.